University of California, Davis
ICOC Committed funds:
Awards as PI
Awards as Co-PI
|Disease Team Therapy Development - Research||MSC engineered to produce BDNF for the treatment of Huntington's disease|
|Early Translational II||Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds|
|Disease Team Therapy Development - Research||Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia|
Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell-derived Induced Pluripotent Stem Cells.
shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.